We recently looked at Goldman Sachs’ Stocks With Highest Consensus Returns: 42 Stocks With The Highest Consensus ROE. In this ...

Leerink has upgraded Gilead Sciences (GILD) to outperform, citing the growth outlook for its PrEP medication lenacapavir for ...

Gilead Sciences (GILD) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

On Saturday, Gilead Sciences, Inc. (NASDAQ:GILD) and Merck & Co. Inc. (NYSE:MRK) revealed new results from a Phase 2 clinical ...

Gilead Sciences (GILD) ended the recent trading session at ... Meanwhile, the Dow lost 0.75%, and the Nasdaq, a tech-heavy index, lost 1.01%. The HIV and hepatitis C drugmaker's shares have ...

In the latest market close, Gilead Sciences (GILD) reached $85.21 ... and the technology-dominated Nasdaq saw an increase of 1.45%. Heading into today, shares of the HIV and hepatitis C drugmaker ...

We recently made a list of Goldman Sachs’ List Of Stocks Popular With Mutual Fund Managers: Top 20 Stocks. In this piece, we ...

Fintel reports that on October 17, 2024, Bernstein initiated coverage of Gilead Sciences (SNSE:GILD) with a Outperform recommendation. What is the Fund Sentiment? There are 2,823 funds or ...

Below is Validea's guru fundamental report for GILEAD SCIENCES, INC. (GILD). Of the 22 guru strategies we follow, GILD rates highest using our Earnings Yield Investor model based on the published ...

Fintel reports that on October 17, 2024, Bernstein initiated coverage of Gilead Sciences (WBAG:GILD) with a Outperform recommendation. What is the Fund Sentiment? There are 2,823 funds or ...